AstraZeneca (NASDAQ:AZN) Coverage Initiated at Morgan Stanley
Analysts at Morgan Stanley assumed coverage on shares of AstraZeneca (NASDAQ:AZN – Get Free Report) in a research note issued on Wednesday, Marketbeat.com reports. The firm set an “overweight” rating on the stock. Several other brokerages have also recently commented on AZN. Deutsche Bank Aktiengesellschaft upgraded shares of AstraZeneca from a “sell” rating to a […]
Analysts at Morgan Stanley assumed coverage on shares of AstraZeneca (NASDAQ:AZN – Get Free Report) in a research note issued on Wednesday, Marketbeat.com reports. The firm set an “overweight” rating on the stock. Several other brokerages have also recently commented on AZN. Deutsche Bank Aktiengesellschaft upgraded shares of AstraZeneca from a “sell” rating to a […]
